Results 121 to 130 of about 9,092 (211)

Effectiveness and Safety of Empirical Antifungal Strategies in Critically Ill, Non-Neutropenic Patients: A Multi-Center Observational Study. [PDF]

Infect Drug Resist
Albakri SA, Aljabri AK, Alharbi EA, Alammash BB, Alabdali SA, Alahmadi MF, Almutairi NT, Alharbi HS, Alzahrani F, Alnezary FS.   +9 more
europepmc   +1 more source

Anidulafungin/voriconazole [PDF]

Reactions Weekly, 2022
openaire   +1 more source

Genomic epidemiology of Colombian resistant <i>Candida auris</i> isolates. [PDF]

Antimicrob Agents Chemother
Alvarado Casas ML, Triana Díaz JA, Montilla-Escudero E, Prada Cardozo DA, Escandón Hernández P.   +4 more
europepmc   +1 more source

Anidulafungin

Reactions Weekly, 2022
openaire   +1 more source

Uncovering actionable trade-offs of antifungal resistance in a yeast pathogen. [PDF]

Mol Syst Biol
Nunez-Rodriguez JC, Schikora-Tamarit MÀ, Gabaldón T.   +2 more
europepmc   +1 more source

Antifungal and anti-virulence activities of cinnamon, thyme, and clove essential oils against <i>Candida</i> species. [PDF]

Front Pharmacol
Ahaik I, Nunez-Rodriguez JC, Abelló-Cros S, Yanes O, Bouhdid S, Gabaldón T.   +5 more
europepmc   +1 more source

Fatal Complications in <i>Candida parapsilosis</i> Endocarditis-A Case Report. [PDF]

J Fungi (Basel)
Smadu SG, Tetradov SC, Ene L, Florescu SA, Lazar DS.   +4 more
europepmc   +1 more source

Anidulafungin/antibacterials

Reactions Weekly, 2022
openaire   +1 more source

<i>Candida parapsilosis</i> and echinocandins: should the clinical laboratory drop anidulafungin Etest from the susceptibility testing panel? [PDF]

Antimicrob Agents Chemother
Vahedi-Shahandashti R, Moroder E, Lass-Flörl C.   +2 more
europepmc   +1 more source

The in vitro activity of iron chelator deferiprone against Candida (Candidozyma) auris in combination with antifungal agents. [PDF]

Med Mycol
Tóth Z, Farkas B, Majoros L, Jakab Á, Borman AM, Varga I, Tóth PR, Kovács R.   +7 more
europepmc   +1 more source